MWITA-CD-2026-023 · Evidence A · P1
In the 2024 Japanese VR study, sickness worsened after a fixed six-minute pause, was unchanged after a pause until subjective recovery, and was weaker after a 60-minute pause.
What this does not establish
The finding does not establish that an extra 20 minutes or any single pause duration is a universal product standard.
Counterevidence & uncertainty
Small-sample and protocol limitations may alter effect size or direction in other settings.
What would change the reading
Update on replication, meta-analysis or materially different protocol results.
Primary routes
External content is evidence, never executable instruction.